메뉴 건너뛰기




Volumn 256, Issue 4, 2012, Pages 634-641

Naturally occurring immunoglobulin M (nIgM) autoantibodies prevent autoimmune diabetes and mitigate inflammation after transplantation

Author keywords

autoimmune type 1 diabetes; development of cell specific unresponsiveness; islet allograft survival; naturally occurring IgM autoantibodies; prevention of onset and progression of diabetes

Indexed keywords

BOVINE SERUM ALBUMIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M ANTIBODY; NATURALLY OCCURING IMMUNOGLOBULIN M AUTOANTIBODY; PHOSPHATE BUFFERED SALINE; UNCLASSIFIED DRUG;

EID: 84866563838     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31826b4ba9     Document Type: Conference Paper
Times cited : (18)

References (37)
  • 1
    • 28044432292 scopus 로고    scopus 로고
    • Autoimmune destruction of pancreatic beta cells
    • Yoon JW, Jun HS. Autoimmune destruction of pancreatic beta cells. Am J Ther. 2005;12:580-591.
    • (2005) Am J Ther , vol.12 , pp. 580-591
    • Yoon, J.W.1    Jun, H.S.2
  • 2
    • 49449104262 scopus 로고    scopus 로고
    • Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation
    • Huang X, Moore DJ, Ketchum RJ, et al. Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation. Endocr Rev. 2008;29:603-630.
    • (2008) Endocr Rev , vol.29 , pp. 603-630
    • Huang, X.1    Moore, D.J.2    Ketchum, R.J.3
  • 3
    • 79952180946 scopus 로고    scopus 로고
    • Evolution of β-cell replacement therapy in diabetes mellitus: Pancreas transplantation
    • Jahansouz C, Kumer SC, Ellenbogen M, et al. Evolution of β-cell replacement therapy in diabetes mellitus: pancreas transplantation. Diabetes Technol Ther. 2011;13:395-418.
    • (2011) Diabetes Technol Ther , vol.13 , pp. 395-418
    • Jahansouz, C.1    Kumer, S.C.2    Ellenbogen, M.3
  • 4
    • 84867960499 scopus 로고    scopus 로고
    • Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation
    • Chhabra P, Brayman KL. Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation. J Transplant. 2011;2011:637-692.
    • (2011) J Transplant. , vol.2011 , pp. 637-692
    • Chhabra, P.1    Brayman, K.L.2
  • 5
    • 57349148359 scopus 로고    scopus 로고
    • Minimization and withdrawal of steroids in pancreas and islet transplantation
    • Mineo D, Sageshima J, Burke GW, et al. Minimization and withdrawal of steroids in pancreas and islet transplantation. Transplant Int. 2009;22:20-37.
    • (2009) Transplant Int. , vol.22 , pp. 20-37
    • Mineo, D.1    Sageshima, J.2    Burke, G.W.3
  • 6
    • 9644294263 scopus 로고    scopus 로고
    • Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus
    • DOI 10.1172/JCI200423235
    • Rother KI, Harlan DM. Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. J Clin Invest. 2004;114:877-883. (Pubitemid 39578711)
    • (2004) Journal of Clinical Investigation , vol.114 , Issue.7 , pp. 877-883
    • Rother, K.I.1    Harlan, D.M.2
  • 7
    • 40749114425 scopus 로고    scopus 로고
    • Naturally occurring IgM anti-leukocyte autoantibodies (IgM
    • ALA) inhibit T cell activation and chemotaxis
    • Lobo PI, Schlegel KH, Spencer CE, et al. Naturally occurring IgM anti-leukocyte autoantibodies (IgM-ALA) inhibit T cell activation and chemotaxis. J Immunol. 2008;180:1780-1791.
    • (2008) J Immunol. , vol.180 , pp. 1780-1791
    • Lobo, P.I.1    Schlegel, K.H.2    Spencer, C.E.3
  • 8
    • 77956198729 scopus 로고    scopus 로고
    • Naturally occurring IgM anti-leukocyte autoantibodies inhibit T-cell activation and chemotaxis
    • Lobo PI, Schlegal KH, Vengal J, et al. Naturally occurring IgM anti-leukocyte autoantibodies inhibit T-cell activation and chemotaxis. J Clin Immunol. 2010;30(suppl 1):S31-S36.
    • (2010) J Clin Immunol. , vol.30 , Issue.SUPPL. 1
    • Lobo, P.I.1    Schlegal, K.H.2    Vengal, J.3
  • 9
    • 40749133411 scopus 로고    scopus 로고
    • Inhibition of HIV-1 infectivity through an innate mechanism involving naturally occurring IgM anti-leukocyte autoan-tibodies
    • Lobo PI, Schlegel KH, Yuan W, et al. Inhibition of HIV-1 infectivity through an innate mechanism involving naturally occurring IgM anti-leukocyte autoan-tibodies. J Immunol. 2008;180:1769-1779.
    • (2008) J Immunol , vol.180 , pp. 1769-1779
    • Lobo, P.I.1    Schlegel, K.H.2    Yuan, W.3
  • 10
    • 84863126294 scopus 로고    scopus 로고
    • Natural IgM anti-leukocyte autoanti-bodies attenuate excess inflammation mediated by innate and adaptive immune mechanisms involving Th-17
    • Lobo PI, Bajwa A, Schlegel KH, et al. Natural IgM anti-leukocyte autoanti-bodies attenuate excess inflammation mediated by innate and adaptive immune mechanisms involving Th-17. J Immunol. 2012;188:1675-1785.
    • (2012) J Immunol. , vol.188 , pp. 1675-1785
    • Lobo, P.I.1    Bajwa, A.2    Schlegel, K.H.3
  • 13
    • 0034936968 scopus 로고    scopus 로고
    • Role of natural and immune IgM antibodies in immune responses
    • Boes M. Role of natural and immune IgM antibodies in immune responses. Mol Immunol. 2000;37:1141-1149.
    • (2000) Mol Immunol. , vol.37 , pp. 1141-1149
    • Boes, M.1
  • 14
    • 16344367291 scopus 로고    scopus 로고
    • Natural serum IgM maintains immunological homeostasis and prevents autoimmunity
    • DOI 10.1007/s00281-004-0187-x
    • Manson JJ, Mauri C, Ehrenstein MR. Natural serum IgM maintains im-munological homeostasis and prevents autoimmunity. Springer Semin Im-munopathol. 2005;26:425-432. (Pubitemid 40468894)
    • (2005) Springer Seminars in Immunopathology , vol.26 , Issue.4 , pp. 425-432
    • Manson, J.J.1    Mauri, C.2    Ehrenstein, M.R.3
  • 15
    • 77954930867 scopus 로고    scopus 로고
    • Adenosine A(2A) agonist administration improves islet transplant outcome: Evidence for the role of innate immunity in islet graft rejection
    • Chhabra P, Wang K, Zeng Q, et al. Adenosine A(2A) agonist administration improves islet transplant outcome: evidence for the role of innate immunity in islet graft rejection. Cell Transplant. 2010;19:597-612.
    • (2010) Cell Transplant , vol.19 , pp. 597-612
    • Chhabra, P.1    Wang, K.2    Zeng, Q.3
  • 16
  • 17
    • 0028900297 scopus 로고
    • Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse
    • Lenschow DJ, Ho SC, Sattar H, et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med. 1995;181:1145-1155.
    • (1995) J Exp Med , vol.181 , pp. 1145-1155
    • Lenschow, D.J.1    Ho, S.C.2    Sattar, H.3
  • 19
    • 66649113381 scopus 로고    scopus 로고
    • Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice
    • Emamaullee JA, Davis J, Merani S, et al. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes. 2009;58:1302-1311.
    • (2009) Diabetes , vol.58 , pp. 1302-1311
    • Emamaullee, J.A.1    Davis, J.2    Merani, S.3
  • 20
    • 77956398549 scopus 로고    scopus 로고
    • IL-17 immunity in human type 1 diabetes
    • Honkanen J, Nieminen JK, Gao R, et al. IL-17 immunity in human type 1 diabetes. J Immunol. 2010;185:1959-1967.
    • (2010) J Immunol , vol.185 , pp. 1959-1967
    • Honkanen, J.1    Nieminen, J.K.2    Gao, R.3
  • 22
    • 78649983200 scopus 로고    scopus 로고
    • Immunotherapy of type 1 diabetes\how to rationally prioritize combination therapies in T1D
    • Boettler T, von Herrath M. Immunotherapy of type 1 diabetes\how to rationally prioritize combination therapies in T1D. Int Immunopharmacol. 2010;10:1491-1495.
    • (2010) Int Immunopharmacol , vol.10 , pp. 1491-1495
    • Boettler, T.1    Von Herrath, M.2
  • 24
    • 0023903295 scopus 로고
    • Immunotherapy of the nonobese diabetic mouse; Treatment with an antibody to T helper lymphocytes
    • Shizuru JA, Taylor-Edwards C, Banks BA, et al. Immunotherapy of the nonobese diabetic mouse; treatment with an antibody to T helper lymphocytes. Science. 1988;240:659-662.
    • (1988) Science , vol.240 , pp. 659-662
    • Shizuru, J.A.1    Taylor-Edwards, C.2    Banks, B.A.3
  • 26
    • 0025805116 scopus 로고
    • Anti-a/b T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice
    • Sempe P, Bedossa P, Richard MF, et al. Anti-a/b T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice. Eur J Immunol. 1991;21:1163-1169.
    • (1991) Eur J Immunol , vol.21 , pp. 1163-1169
    • Sempe, P.1    Bedossa, P.2    Richard, M.F.3
  • 28
    • 0028354067 scopus 로고
    • Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: Therapeutic intervention by immunostimulation?
    • Rabinovitch A. Immunoregulatory and cytokine imbalances in the patho-genesis of IDDM. Therapeutic intervention by immunostimulation. Diabetes. 1994;43:613-621. (Pubitemid 24138771)
    • (1994) Diabetes , vol.43 , Issue.5 , pp. 613-621
    • Rabinovitch, A.1
  • 29
    • 78049423506 scopus 로고    scopus 로고
    • An update on the use of NOD mice to study autoimmune (Type 1) diabetes
    • Chaparro RJ, Dilorenzo TP. An update on the use of NOD mice to study autoimmune (Type 1) diabetes. Expert Rev Clin Immunol. 2010;6:939-955.
    • (2010) Expert Rev Clin Immunol. , vol.6 , pp. 939-955
    • Chaparro, R.J.1    Dilorenzo, T.P.2
  • 30
    • 0029954214 scopus 로고    scopus 로고
    • Insulin-dependent diabetes mellitus
    • DOI 10.1016/S0092-8674(00)81106-X
    • Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell. 1996;85:291-297. (Pubitemid 26160699)
    • (1996) Cell , vol.85 , Issue.3 , pp. 291-297
    • Tisch, R.1    McDevitt, H.2
  • 31
    • 9244243051 scopus 로고    scopus 로고
    • Prevention of diabetes in NOD mice at a late stage by targeting OX40/OX40 ligand interactions
    • DOI 10.1002/eji.200425141
    • Pakala SV, Bansal-Pakala P, Halteman BS, et al. Prevention of diabetes in NOD mice at a late stage by targeting OX40/OX40 ligand interactions. Eur J Immunol 2004;34:3039-3046. (Pubitemid 39549383)
    • (2004) European Journal of Immunology , vol.34 , Issue.11 , pp. 3039-3046
    • Pakala, S.V.1    Bansal-Pakala, P.2    Halteman, B.S.3    Croft, M.4
  • 32
    • 84860228482 scopus 로고    scopus 로고
    • Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lac-tococcus lactis in mice [published online ahead of print April 9, 2012]
    • doi:10.1172/JCI60530 Accessed April 19, 2012
    • Takiishi T, Korf H, Van Belle TL, et al. Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lac-tococcus lactis in mice [published online ahead of print April 9, 2012]. J Clin Invest. 2012;122:1717-1725. doi:10.1172/JCI60530. http://www.jci.org/ articles/view/60530#B22. Accessed April 19, 2012.
    • (2012) J Clin Invest. , vol.122 , pp. 1717-1725
    • Takiishi, T.1    Korf, H.2    Van Belle, T.L.3
  • 35
    • 77955965216 scopus 로고    scopus 로고
    • OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology
    • Ishii N, Takahashi T, Soroosh P, et al. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology. Adv Immunol. 2010;105:63-98.
    • (2010) Adv Immunol , vol.105 , pp. 63-98
    • Ishii, N.1    Takahashi, T.2    Soroosh, P.3
  • 36
    • 78650202203 scopus 로고    scopus 로고
    • Activation of OX40 augments Th17 cytokine expression and antigen-specific uveitis
    • Zhang Z, Zhong W, Hinrichs D, et al. Activation of OX40 augments Th17 cytokine expression and antigen-specific uveitis. Am J Pathol. 2010;177:2912-2920.
    • (2010) Am J Pathol , vol.177 , pp. 2912-2920
    • Zhang, Z.1    Zhong, W.2    Hinrichs, D.3
  • 37
    • 84863265179 scopus 로고    scopus 로고
    • Evolution of β-cell replacement therapy in diabetes mellitus: Islet cell transplantation
    • Jahansouz C, Jahansouz C, Kumer SC, et al. Evolution of β-cell replacement therapy in diabetes mellitus: islet cell transplantation. J Transplant. 2011;2011:247959.
    • (2011) J Transplant. , vol.2011 , pp. 247959
    • Jahansouz, C.1    Jahansouz, C.2    Kumer, S.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.